Preliminary inquiry and Sample request

        

Step 1 Preliminary inquiry of samples and data

FINGENIOUSTM is a service administered by the Biobank Cooperative Finland (FINBB), through which you can make a preliminary inquiry or a request for samples to any of the six Finnish hospital biobanks. If you wish, you can reach all six hospital biobanks with one application. The service includes Auria Biopankki, Helsinki Biobank, Biobank of Eastern Finland, Biobank of Central Finland, Borealis Biobank in Northern Finland and Biobank of Tampere.

In the preliminary inquiry phase, it is confirmed whether the biobank can provide you the samples and/or associated data needed in your research. You will receive reply to the inquiry in 1-3 weeks. Please note that Helsinki biobank's reply to the Preliminary Request is a mandatory annex to the HUS's Ethics Committee Opinion.

In order to submit a new preliminary inquiry, you must first register with FINGENIOUSTM.

FINGENIOUSTM does not work with Internet Explorer. Please choose Google Chrome or Mozilla Firefox browser to access FINGENIOUSTM electronic service.

Sign up for FINGENIOUSTM here.

Log in to FINGENIOUSTM here.

 

The process for acquiring samples and associated data from Helsinki Biobank.

 

Step 2 Ethical review

All studies requiring materials from Helsinki Biobank must undergo an ethical review before the submission of a sample request.

Please use the HUS' “Tutkijan Työpöytä" platform for submitting an electronic application to the HUS Ethics Committees. If your research has received a favorable opinion from another Ethics or Scientific ethics Committee, a second opinion is not necessary. Helsinki Biobank's statement on the availability of samples (see step 1) is a mandatory annex to the application for an ethical review. You can find more instructions and a list of required documents here.

The “Tutkijan Työpöytä"-platform requires a Finnish ID number for the user to be able to log in. If your research group has no Finnish collaborators, Helsinki Biobank's personnel will fill in the form for you.

The ethical review takes approximately one month to be completed. You can send your application concerning biobank research to anyone of the Ethics Committees. Depending on the funding sources and the nature of the study, there may be a fee for the ethical review (STM lausuntomaksuasetus 840/2010).

GO TO "TUTKIJAN TYÖPÖYTÄ" https://tutkija.hus.fi

 

Step 3 Sample request  

 

FINGENIOUSTM is a service administered by the Biobank Cooperative Finland (FINBB), through which you can make a preliminary inquiry or a request for samples to any of the six Finnish hospital biobanks. If you wish, you can reach all six hospital biobanks with one application. The service includes Auria Biopankki, Helsinki Biobank, Biobank of Eastern Finland, Biobank of Central Finland, Borealis Biobank in Northern Finland and Biobank of Tampere.

Once you have completed the preliminary inquiry via FINGENIOUSTM and received a favorable opinion from the Ethics Committee to conduct your research, you can submit a request for samples and data to Helsinki Biobank.    

FINGENIOUSTM does not work with Internet Explorer. Please choose Google Chrome or Mozilla Firefox browser to access FINGENIOUSTM.

Log in to FINGENIOUSTM here.

 

Step 4: Final decision, MTA and the delivery of samples and data 

 

The final decision of approval is made by the Medical Director of HUS based on the recommendation of Helsinki Biobank. Upon the final approval of your sample request, the Materials Transfer Agreement (MTA) will be provided to you. This agreement includes also a description of costs. The principal investigator and a representative of his/her back organization shall sign the MTA before the delivery of samples and/or data. The back organization can be a Finnish or an international research institute or company.

The time for completion of the process and material dispatch depends on the type and quantity of the samples requested, and on the capabilities of the research team, if necessary, to assist with clinical expertise.

Please note that although the study has a valid decision and an MTA, Helsinki Biobank cannot guarantee the delivery of samples. The final selection of samples will always be done in collaboration with clinicians, taking into account the primary need for clinical use of the samples, the quality, size or staining of the samples, and the patient's medical history and other possible exclusion criteria.

Step 5: Return of Data

 

Helsinki Biobank requires that the raw data /results obtained from the analyses shall be returned to the biobank, to be later available to other projects. The format and timetable for data return will be specified in the MTA. Depending on the nature of the study, we may agree on forwarding the raw data only after you have published the results. 

 

Päivitetty  2.5.2019 10.27